Everest Biopharma International Inc.

The value Proposition

Everest’s is a closely held private company with eligible corporation status ("EBC") with the BC government allowing for a 30 % tax credit for BC investors.

Our investment objectives to remain private and  pay shareholders large dividends on a quarterly basis with  an early exit within 24 months of license grant.

Everest's present valuation is conservatively estimated to be $3.5M with its COR and after receiving its processing license end of Q1 will be valued at $15M based on recent transactions in the Canadian public markets.

The Corporation will capitalize on existing expertise and experience from the existing team in previously setting up state of the art biotechnology laboratories, technical qualifications in biochemistry, standard operating procedures, and strict regulatory compliance as well as project management, business, accounting and finance expertise, and 8 years of consulting experience in the Canadian legal cannabis industry.

105287657 - close up.young businessman shaking hands with investor